Mirina Closes Series A-1 Financing to Support miRNA Drug Development
April 29, 2010
Mirina Closes Series A-1 Financing to Support miRNA Drug Development
While the amount of the funding was not disclosed, an official from the investment firm that founded Mirina said that it is sufficient to fund the company's operations for 12 to 15 months.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Groove Raises $6M to Fund Operations Through 2012
December 15, 2011 / Gene Silencing News - Mirna Series B Sees Slight Delay as miRNA Rx Field Grows
October 21, 2010 / Gene Silencing News - In 2012, Top microRNA Drug Developers Pull in Nearly $150M in Funding
December 20, 2012 / Gene Silencing News - Regulus Grosses a Total of $80.9M from Recent Transactions
November 8, 2012 / Gene Silencing News - Mirna Closes $34.5M Series C Round as microRNA Drugs Gain Investor Interest
October 25, 2012 / Gene Silencing News